跳至主要内容
临床试验/NCT07351240
NCT07351240进行中(未招募)不适用

The Quality of Life of Acupuncture Treatment Effect in Patients With Schizophrenia

Calo Psychiatric Center0 个研究点目标入组 100 人开始时间: 2025年12月16日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

Among various psychiatric disorders, this study focuses specifically on patients with schizophrenia. The aim of this study is to evaluate the therapeutic effects of acupuncture on antipsychotic medication-related side effects and psychiatric symptoms in patients with schizophrenia. This is a single-blind randomized study. Participants will be randomly assigned to one of two groups: Neiguan and Shenmen. Both the Neiguan and Shenmen groups will receive acupuncture treatment twice weekly, with each session lasting 30 minutes, for a total of four consecutive weeks. Assessments will be conducted prior to acupuncture intervention and after each acupuncture session. All assessment data will be collected and analyzed using statistical methods including descriptive statistics, chi-square tests, and t-tests. Generalized Estimating Equations (GEE-I) and multiple linear regression analyses will be applied to examine differences in psychological health, quality of life, and happiness before and after acupuncture intervention. It is anticipated that acupuncture will reduce antipsychotic-related side effects, improve psychiatric symptoms in patients with schizophrenia, and subsequently enhance patients' quality of life and happiness.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

盲法说明

Participants will be randomly assigned to either the Neiguan group or the Shenmen group.

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of schizophrenia according to DSM-5 criteria for at least six months
  • Personal and Social Performance Scale score ≥ 50

排除标准

  • Severe medical illnesses (e.g., cancer, chronic liver disease, renal failure)
  • History of stroke or other causes of hemiplegia
  • Severe dermatological disease or limb edema
  • High risk of violence or suicide
  • Alcohol or substance abuse or dependence
  • Severe cognitive impairment
  • Pregnancy or breastfeeding
  • Severe hepatic, renal, cardiac, pulmonary, or hematological disease
  • Major infectious diseases (e.g., HIV infection)
  • Refusal to provide informed consent

研究者

发起方
Calo Psychiatric Center
申办方类型
Other
责任方
Sponsor

相似试验